Negative regulation of complement activation

pathway activity — cross-omics
GO:0045916Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of complement activation pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SLIT3, HTR2A, and SVEP1, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of complement activation activity versus SLIT3 in BRCA (Pearson r = 0.19).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCASLIT3 →+1.085+0.217<.001<.00138
GBMHTR2A →+0.850+0.121<.001<.00137
OVSVEP1 →+1.314+0.183<.001<.00137
BRCAGAS6 →+0.989+0.200<.001<.00137
OVTMEM119 →+1.395+0.149<.001<.00137
OVSTAB1 →+1.440+0.235<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0045916 vs SLIT3 — BRCA

Per-sample scatter of Negative regulation of complement activation activity vs SLIT3 in BRCA.

Explore this scatter interactively →

Exploration